Halofantrine hydrochloride
SIGMA/H9414 - ≥98% (HPLC), solid
Synonym: 1,3-
CAS Number: 36167-63-2
Empirical Formula (Hill Notation): C26H30Cl2F3NO · HCl
Molecular Weight: 536.88
EC Number: 252-895-4
MDL Number: MFCD00879136
Linear Formula: C26H30Cl2F3NO · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | solid |
| InChI | 1S/C26H30Cl2F3NO.ClH/c1-3 |
| InChI key | WANGFTDWOFGECH-UHFFFAOYSA |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CCCCN(CCCC)CCC(O)c1cc2 |
| solubility | DMSO: >10 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Halofantrine is a blocker of delayed rectifier potassium current via the inhibition of hERG channel. |
| Features and Benefits: | This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Hazard statements | H413 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

